2seventy bio, Inc. (TSVT)

2seventy bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-223.22	-217.57	-254.15	-292.21	-120.11	-320.59
Depreciation & Amortization	10.14	10.29	11.53	16.35	13.19	12.59
Share-Based Compensation	27.18	32.16	41.04	54.63	61	62.05
Other Operating Activities	26.26	8.27	-26.56	14.38	-21.86	38
Operating Cash Flow	-159.65	-166.86	-228.14	-206.86	-67.79	-207.96
Capital Expenditures	-8.22	-13.87	-30.81	-11.58	-22.26	-59.77
Change in Investments	29.12	57.73	34.56	1.99	0	0
Other Investing Activities	-	-	-	-8	-	-
Investing Cash Flow	20.9	43.86	3.75	-17.59	-22.26	-59.77
Share Issuance / Repurchase	0.69	127.39	166.23	0	0	0
Other Financing Activities	-	-	-	354.89	90.05	267.72
Financing Cash Flow	0.69	127.39	166.23	354.89	90.05	267.72
Net Cash Flow	-138.06	4.39	-58.16	130.45	0	0
Free Cash Flow	-167.87	-180.72	-258.95	-218.43	-90.05	-267.72
Free Cash Flow Margin	-235.77%	-180.03%	-283.02%	-400.63%	-36.29%	-604.39%
Free Cash Flow Per Share	-3.22	-3.67	-7.27	-9.29	-3.85	-11.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).